ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010

In Brief: NCI Sent 82 Staff Members to Florence, 75 Of Whom Were Supported By ACS-NAS Pool

November 8, 1974

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

In Brief: Ames Test Pinpoint Pickles, Cigarettes; AACR Majority Supports Cancer Congress

February 3, 1978

NIH Begins Process Of Extramural Program “Reinvention”

July 22, 1994